The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing
AbstractExtreme point-of-care (POC) testing for infections, as performed (endured) in low-resource settings, developing countries, tropical areas, or in conditions following emergency crises or natural disasters, must be undertaken under environmental, logistic, and societal conditions which impose a significant deal of stress on local human populations and healthcare providers. For disease diagnostics or management, simple and robust biomedical equipment and reagents are required and needed. This chapter aims to overview some of these stresses (requirements) and intends to describe some of the solutions already engineered at the heart of centripetal (centrifugal) microfluidic platforms such as that of GenePOC Inc. to enable rapid, robust, and reproducible nucleic acid-based diagnostics of infectious diseases, to better control the morbidity and mortality of infections and the expanding threat posed by antimicrobial resistance. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Bissonnette, L.; Bergeron, M.G. The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing. Micromachines 2016, 7, 94.
Bissonnette L, Bergeron MG. The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing. Micromachines. 2016; 7(6):94.Chicago/Turabian Style
Bissonnette, Luc; Bergeron, Michel G. 2016. "The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing." Micromachines 7, no. 6: 94.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.